|
1. American Cancer Society (2023). https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html 2. Barrett A, Morris S, Dobbs J, Roques T (2009) Practical radiotherapy planning. CRC Press, United States. [ DOI:10.1201/b13373] 3. Videtic GM, Vassil AD, Woody NM (2020) Handbook of treatment planning in radiation oncology. Springer, United States. [ DOI:10.1891/9780826168429] 4. Khan FM, Sperduto PW, Gibbons JP (2021) Khan's Treatment Planning in Radiation Oncology. Lippincott Williams & Wilkins, United States. 5. Nishimura Y and Komaki R (2015) Intensity-modulated radiation therapy: clinical evidence and techniques. Springer, United States. [ DOI:10.1007/978-4-431-55486-8] 6. Sale C and Moloney P (2011) Dose comparisons for conformal, IMRT and VMAT prostate plans. J Med Imag Radiat Oncol, 55(6): 611-21. [ DOI:10.1111/j.1754-9485.2011.02310.x] 7. Yang B, Zhu L, Cheng H, Li Q, Zhang Y, Zhao Y (2012) Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis. Radiat oncol, 7(1): 1-11. [ DOI:10.1186/1748-717X-7-197] 8. Pollack A, Hanlon A, Horwitz EM, Feigenberg S, Uzzo RG, Price RA (2003) Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. World Journal of Urology, 21(4): 200-8. [ DOI:10.1007/s00345-003-0356-x] 9. van Schie MA, Janssen TM, Eekhout D, Walraven I, Pos FJ, de Ruiter P, Kotte AN, et al. (2020) Knowledge-based assessment of focal dose escalation treatment plans in prostate cancer. Int J Radiat Oncol Biol Phys, 108(4): 1055-62. [ DOI:10.1016/j.ijrobp.2020.06.072] 10. Azzeroni R, Maggio A, Fiorino C, Mangili P, Cozzarini C, De Cobelli F, et al. (2013) Biological optimization of simultaneous boost on intra-prostatic lesions (DILs): sensitivity to TCP parameters. Physica Medica, 29(6): 592-8. [ DOI:10.1016/j.ejmp.2012.10.002] 11. Mahdavi SR, Gharehbagh EJ, Nikoofar AR, Mofid B, Vasheghani M, Saedi D (2017) Radiation treatment planning for prostate cancer: A new dosimetric comparison of five and seven fields IMRT plans. Int J Radiat Res, 15(2):177-183. [ DOI:10.18869/acadpub.ijrr.15.2.177] 12. Bhardwaj AK, Sharma S, Oinam A, Kehwar T, Chakarvarti S (2007) 3-Dimensional conformal radiotherapy versus intensity modulated radiotherapy for localized prostate cancer: Dosimetric and radiobiologic analysis. Int J Radiat Res, 5(1): 1-8. [ DOI:10.4103/0973-1482.31967] 13. Adeneye S, Akpochafor M, Habeebu M, Omojola A, Joseph A, Awhariado J, et al. (2021) Dosimetric evaluation of intensity modulated radiotherapy and three-dimensional conformal radiotherapy treatment plans for prostate cancer. Turk J Oncol, 36(1):104-11. [ DOI:10.5505/tjo.2020.2437] 14. Fowler JF (2005) The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncologica, 44(3): 265-76. [ DOI:10.1080/02841860410002824] 15. Deb P and Fielding A (2009) Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer. Australasian Physics & Engineering Sciences in Medicine, 32(2): 51-61. [ DOI:10.1007/BF03178629] 16. Das S (2009) A role for biological optimization within the current treatment planning paradigm. Med Physics, 36(10): 4672-82. [ DOI:10.1118/1.3220211] 17. Senthilkumar K and Das KM (2019) Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system. J Cancer Res Therapeutics, 15(8): 33. [ DOI:10.4103/jcrt.JCRT_956_16] 18. Mesbahi A, Rasouli N, Mohammadzadeh M, Nasiri Motlagh B, Ozan Tekin H (2019) Comparison of radiobiological models for radiation therapy plans of prostate cancer: three-dimensional conformal versus intensity modulated radiation therapy. J Biomed Phys & Engineering, 9(3): 267. [ DOI:10.31661/jbpe.v9i3Jun.655] 19. Emami B (2013) Tolerance of normal tissue to therapeutic radiation. Reports of Radiotherapy and Oncology, 1(1): 123-7. 20. Sujenthiran A, Nossiter J, Charman SC, Parry M, Dasgupta P, van der Meulen J, et al. (2017) National population-based study comparing treatment-related toxicity in men who received intensity modulated versus 3-dimensional conformal radical radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys, 99(5):1253-60. [ DOI:10.1016/j.ijrobp.2017.07.040] 21. Shimizuguchi T, Nihei K, Okano T, Machitori Y, Ito K, Karasaw(2017) A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Int J Clinical Oncology, 22(2): 373-9. [ DOI:10.1007/s10147-016-1057-y] 22. Cakir A, Akgun Z, Fayda M, Agaoglu F (2015) Comparison of three-dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer. Asian Pacific J Cancer Prevention, 16(8): 3365-70. [ DOI:10.7314/APJCP.2015.16.8.3365] 23. AL-Shareef J, Attalla E, Khalil M, Abdelaal A, El-Nagdy M (2020) Comparison of intensity modulated and 3-dimensional conformal radiotherapy for prostate cancer using 6-MV and 15-MV photon energies. Arab J Nuclear Sciences and Applications, 53(2):189-200. [ DOI:10.21608/ajnsa.2020.19402.1296] 24. Vaezzadeh SA, Allahverdi M, Nedaie HA, Aghili M, Esfehani M (2012) Comparison of conventional and 3D conformal treatments using linac energies for prostate cancer. Int J Radiat Res, 10(3-4): 145-150.
|